Covered recipient · General Payments record
AMBER LEE LICHTENBARGER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,114.72
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.52 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $41.27 | 3 |
| Novo Nordisk AS | $36.88 | 2 |
| Acerta Pharma LLC | $34.89 | 2 |
| PFIZER INC. | $32.94 | 2 |
| EISAI INC. | $18.33 | 1 |
| DEXCOM, INC. | $17.47 | 1 |
| ABBVIE INC. | $16.82 | 1 |
| Lundbeck LLC | $15.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 1 |
| Insulet Corporation | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.82 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879989 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104345624 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.41 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104678991 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118170124 | CMS |
| Dexcom, Inc. | $17.47 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278397 | CMS |
| Eisai Inc. | $18.33 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110728527 | CMS |
| Insulet Corporation | $13.08 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116805082 | CMS |
| Lilly USA, LLC | $13.61 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136029271 | CMS |
| Lilly USA, LLC | $13.80 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024238 | CMS |
| Lilly USA, LLC | $13.86 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024242 | CMS |
| Lundbeck LLC | $15.55 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145939610 | CMS |
| Novo Nordisk Inc | $18.64 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097324973 | CMS |
| Novo Nordisk Inc | $18.24 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097068465 | CMS |
| PFIZER INC. | $18.94 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131490290 | CMS |
| PFIZER INC. | $14.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131177460 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.